Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: An immunohistochemical study of East-Asian-type CagA

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 4, 2011, Pages 688-693

  Abe, Takashi ^a   Kodama, Masaaki ^a   Murakami, Kazunari ^a   Matsunari, Osamu ^a   Mizukami, Kazuhiro ^a   Inoue, Kunimitsu ^a   Uchida, Masahiro ^a   Okimoto, Tadayoshi ^a   Fujioka, Toshio ^a   Uchida, Tomohisa ^a   Moriyama, Masatsugu ^a   Yamaoka, Yoshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Atrophy; CagA; Gastric cancer; Helicobacter pylori; Immunohistochemistry

Indexed keywords

CAGA PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENDOSCOPY; FEMALE; GASTRIC MUCOSAL ATROPHY; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; JAPAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH MUCOSA LESION;

EID: 79952854424     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06565.x     Document Type: Article

References (33)

1. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
2. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst. 1995; 87: 1777-80.
3. Take S, Mizuno M, Ishiki K etal. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am. J. Gastroenterol. 2005; 100: 1037-42.
4. Uemura N, Okamoto S, Yamamoto S etal. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345: 784-9.
5. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian-gerbils. Cancer Res. 1998; 58: 4255-9.
6. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-6.
7. Fukase K, Kato M, Kikuchi S etal. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet 2008; 372: 392-7.
8. Blaser MJ, Perez-Perez GI, Kleanthous H etal. Infection with Helicobacter pylori strains possessing cag A is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55: 2111-5.
9. + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 1997; 89: 863-8.
10. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-33.
11. Asahi M, Azuma T, Ito S etal. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 2000; 191: 593-602.
12. Higashi H, Tsutsumi R, Muto S etal. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-6.
13. Feng GS, Hui CC, Pawson T. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 1993; 259: 1607-11.
14. Freeman RM Jr, Plutzky J, Neel BG. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc. Natl. Acad. Sci. U S A. 1992; 89: 11239-43.
15. Yu DH, Qu CK, Henegariu O, Lu X, Feng GS. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J. Biol. Chem. 1998; 273: 21125-31.
16. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 1998; 36: 2258-63.
17. Yamaoka Y, El-Zimaity HM, Gutierrez O etal. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999; 117: 342-9.
18. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 2004; 4: 688-94.
19. Hatakeyama M. Helicobacter pylori CagA: a bacterial intruder conspiring gastric carcinogenesis. Int. J. Cancer 2006; 119: 1217-23.
20. Azuma T, Yamakawa A, Yamazaki S etal. Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan. J. Infect. Dis. 2002; 186: 1621-30.
21. Azuma T, Yamazaki S, Yamakawa A etal. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 2004; 189: 820-7.
22. Satomi S, Yamakawa A, Matsunaga S etal. Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J. Gastroenterol. 2006; 41: 668-73.
23. Basso D, Zambon CF, Letley DP etal. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135: 91-9.
24. Uchida T, Kanada R, Tsukamoto Y etal. Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci. 2007; 98: 521-8.
25. Kanada R, Uchida T, Tsukamoto Y etal. Genotyping of the cagA gene of Helicobacter pylori on immunohistochemistry with East Asian CagA-specific antibody. Pathol. Int. 2008; 58: 218-25.
26. Yasuda A, Uchida T, Nguyen LT etal. A novel diagnostic monoclonal antibody specific for Helicobacter pylori CagA of East Asian type. APMIS 2009; 117: 893-9.
27. Nguyen LT, Uchida T, Kuroda A etal. Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping. Clin. Vaccine Immunol. 2009; 16: 1687-92.
28. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am. J. Surg. Pathol. 1996; 20: 1161-81.
29. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
30. Ishiguro N, Baba T, Ishida T etal. Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. Am. J. Pathol. 2002; 160: 1767-78.
31. Rugge M, Meggio A, Pennelli G etal. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-6.
32. Satoh K, Kimura K, Taniguchi Y etal. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am. J. Gastroenterol. 1996; 91: 963-9.
33. Ito S, Azuma T, Murakita H etal. Profile of Helicobacter pylori cytotoxin derived from two areas of Japan with different prevalence of atrophic gastritis. Gut 1996; 39: 800-6.